patent/IL-276145-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a9e9ce63eb0bbf3658453fb50a6d9b
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
filingDate	2020-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2020-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	IL-276145-A
titleOfInvention	Triazolopyrimidine history for use as ghrelin O-acyltransferase inhibitors
priorityDate	2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5327131 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID619373 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481482 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID306515 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID795709 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID234155

Total number of triples: 19.